The prevalence of cardiovascular risk factors in obese children

Irish Medical Journal
|June 12, 2015
PubMed

Insights

Childhood obesity in Ireland is linked to serious health risks like cardiovascular disease. Obese Irish children often have additional risk factors, but increased physical activity can help reduce these risks.

Area of Science:

  • Pediatrics
  • Public Health
  • Cardiology

Background:

  • Childhood obesity is a significant public health concern in Ireland.
  • Obesity in children is associated with metabolic diseases and increased cardiovascular disease risk.
  • Early identification and management of cardiovascular risk factors in obese children are crucial.

Purpose of the Study:

  • To determine the prevalence of cardiovascular risk factors in a cohort of obese Irish children.
  • To investigate the relationship between physical activity levels and cardiovascular risk factors in this population.
  • To highlight the need for targeted interventions in pediatric obesity management.

Main Methods:

  • Cross-sectional study of 59 obese children (21 prepubertal, 38 pubertal/post-pubertal) attending a weight management clinic.
  • Assessment of physical activity levels using pedometers and self-report questionnaires.
  • Metabolic profiling and measurement of BMI, Waist Circumference, and Body Fat percentage.

Main Results:

  • High prevalence of obesity indicated by mean z scores for BMI (+3.29), Waist Circumference (+3.98), and Body Fat % (+2.75).
  • 43% of prepubertal and 68% of pubertal/post-pubertal obese children had at least one additional cardiovascular risk factor.
  • Higher moderate-to-vigorous physical activity levels correlated with a lower incidence of cardiovascular risk factors.

Conclusions:

  • Obese children in Ireland, both prepubertal and pubertal/post-pubertal, exhibit a significant prevalence of cardiovascular risk factors.
  • Physical activity is a key modifiable factor in mitigating cardiovascular risk in obese pediatric populations.
  • Urgent public health strategies are needed to address childhood obesity and its associated health complications in Ireland.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
401
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
345
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
296
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K